Jurnal SINTA 1
The Exploration of Vetiver (Vetiveria zizanioides) as Co-Chemotherapy of Lung Cancer Selectively Targets AKR1C1: Bioinformatics Approach
Indonesian Journal of Cancer Chemoprevention · Vol. 13 No. 2 (2022) · hlm. 114–127
- ISSN
- 2355-8989, 2088-0197
- Terbit
- 2022-06-30
- Penerbit
- Indonesian Society for Cancer Chemoprevention
- Bahasa
- eng
Abstrak
Reactive Oxygen Species (ROS) is one of the cancer-causing agents, one of which is lung cancer. In addition to being carcinogenic, ROS can also be used to kill cancer cells themselves, by increasing their levels to the threshold of apoptosis. Therefore, it is necessary to inhibit certain antioxidant enzymes that are highly expressed in lung cancer. One of them is AKR1C1 which plays a role in the eradication of intracellular ROS. However, AKR1C1 has a high structural similarity to AKR1C2, so it can inhibit therapy causing selectivity problems. Vetiver (Vetiveria zizanioides) has potential as an anticancer. This study was conducted to explore vetiver as a co-chemotherapeutic agent for lung cancer targeting AKR1C1 selectively. The method used is distillation, identification of vetiver compounds using GC-MS, and through bioinformatics studies. Predictive analysis with KNIME was carried out to determine the activity of the test compound. All tested vetiver compounds had a predictive value of 1 (active) on AKR1C1 and 0 (inactive) on AKR1C2. Through GC-MS obtained 354 compounds were identified. These compounds are used to filter the compounds predicted by KNIME. The molecular docking results showed that of the 10 tested vetiver compounds, there was 1 compound that had the strongest bond in interacting with AKR1C1, namely beta vetispirene compound with an S-score of -15.12 kcal/mol, and stronger than native ligand and aspirin. Based on the research data, it can be concluded that the beta vetispirene compound in vetiver can be a potential co-chemotherapy agent for lung cancer in targeting AKR1C1 selectively. However, further research is needed to prove its activity on lung cancer cells.Keywords: ROS (Reactive Oxygen Species), Lung Cancer, AKR1C1, selectivity, vetiver (Vetiveria zizanioides).
Jaringan kolaborasi para penulis
28 penulis · 75 tautan kepenulisan bersama · 8 lintas organisasi
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
- Universitas Gadjah Mada
- Padjadjaran University
- University of Würzburg
- Afiliasi tidak diketahui
- Organisasi berbeda
- Organisasi sama
- Afiliasi tidak diketahui
- Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
| Rekan penulis | Organisasi | Artikel bersama |
|---|---|---|
| Muthi Ikawati | Universitas Gadjah Mada | 2 |
| Edy Meiyanto | Universitas Gadjah Mada | 1 |
| Riris Istighfari Jenie | Universitas Gadjah Mada | 1 |
| Dhiya Ulhaq Salsabila | Padjadjaran University | 1 |
| Nisa Ul Hasanah | Universitas Gadjah Mada | 1 |
| Ahmad Syauqy Tafrihani | Universitas Gadjah Mada | 1 |
| Ummi Maryam Zulfin | Universitas Gadjah Mada | 1 |
| Devyanto Hadi Triutomo | Universitas Gadjah Mada | 1 |
| Amalia Miranda | Universitas Gadjah Mada | 1 |
| Lora Johana Tamba | Universitas Gadjah Mada | 1 |
| Ulrike Holzgrabe | University of Würzburg | 1 |
| Argandita Meiftasari | Universitas Gadjah Mada | 1 |
| Khairunissa Irnanda | Universitas Gadjah Mada | 1 |
| Standie Nagadi | Universitas Gadjah Mada | 1 |
| I Made Rhamandana | Universitas Gadjah Mada | 1 |
| Christina Mutiara Putri Gono | Universitas Gadjah Mada | 1 |
| Masagus Muhammad Prima Putra | Universitas Gadjah Mada | 1 |
| Indun Dewi Puspita | Universitas Gadjah Mada | 1 |
| Winnen Wisnumurti | Universitas Gadjah Mada | 1 |
| Siti Nurul Hidayah | Universitas Gadjah Mada | 1 |
| Prajona Marbun | Afiliasi tidak diketahui | 1 |
| Agung Endro Nugroho | Universitas Gadjah Mada | 1 |
| Annik Megawati | Universitas Gadjah Mada | 1 |
| Arief Nurrochmad | Universitas Gadjah Mada | 1 |
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.